Milestone Scientific (MLSS) Proxy Filing summary

Executive summary

• Annual Meeting scheduled for December 18, 2025, to be held virtually, with record date set as November 4, 2025.

• Key proposals include election of six directors, amendment to increase authorized common stock, and ratification of independent auditors.

• Proxy materials and annual report are available online, and shareholders are encouraged to vote promptly.

• Forward-looking statements are included, subject to risks detailed in annual and quarterly reports.

Voting matters and shareholder proposals

• Shareholders will vote on: (1) election of six directors, (2) amendment to increase authorized shares from 100M to 125M, (3) ratification of CBIZ CPAs P.C. as auditors, and (4) other business as may arise.

• Election of directors requires a plurality of votes; amendment to increase shares requires majority of outstanding shares; auditor ratification requires majority of votes cast.

• Broker non-votes and abstentions have specific effects depending on the proposal.

• Shareholder proposals for the 2026 meeting must be submitted by January 1, 2026.

Board of directors and corporate governance

• Board consists of six members, majority independent, with regular reviews of composition and independence.

• Benedetta Casamento to become Chairman; Neal Goldman to serve as Vice Chairman.

• Board committees include Audit, Compensation, and Nominating and Corporate Governance.

• Board leadership structure separates Chairman and CEO roles for effective governance.

• Stockholder communication process and insider trading policy are in place.